Independent analysis of a clinical predictive algorithm to identify methicillin-resistant Staphylococcus aureus

M Wade Shrader1, Miranda Nowlin, Lee S Segal

  • 1Division of Pediatric Orthopaedic Surgery, Phoenix Children's Hospital, Phoenix, AZ.

Abstract

Insights

A clinical algorithm to predict methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis in children showed poor performance. The algorithm

Area of Science:

  • Pediatric infectious diseases
  • Orthopedic surgery
  • Microbiology

Background:

  • Increasing incidence of severe pediatric musculoskeletal infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
  • Early identification of causative bacteria is crucial for effective antibiotic treatment of osteomyelitis.
  • A prior study developed a clinical algorithm to predict MRSA in pediatric osteomyelitis.

Purpose of the Study:

  • To validate a previously developed clinical algorithm for predicting MRSA osteomyelitis in an independent cohort of pediatric patients.
  • To assess the broader applicability of the MRSA predictive algorithm in a new patient population.

Main Methods:

  • Retrospective chart review of culture-positive osteomyelitis cases in children over a 3-year period at a tertiary care hospital.
  • Evaluation of previously identified predictors: temperature >38°C, hematocrit <34%, WBC >12,000/µL, and CRP >13 mg/L.
  • Correlation of the number of positive predictors with the prevalence of MRSA infection.

Main Results:

  • Out of 58 patients with culture-positive osteomyelitis, 16 (26%) were caused by MRSA.
  • The algorithm showed variable performance: 50% MRSA with 1 risk factor vs. 50% with 4 risk factors.
  • Prevalence of MRSA ranged from 0% (0 risk factors) to 50% (4 risk factors).

Conclusions:

  • The clinical predictive algorithm demonstrated poor diagnostic performance in this independent cohort.
  • Discrepancies in MRSA prevalence suggest limitations due to bacterial strain, host factors, or other confounders.
  • Future research may focus on genetic markers for more accurate early detection of MRSA infections.